Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Annuities

Caramadre’s client list revealed

X
Your article was successfully shared with the contacts you provided.

CRANSTON, R.I. – Terence McAuliffe, the former chairman of the national Democratic Party and current Virginia governor-elect, was one of hundreds of people who invested in variable annuities that used terminally ill patients as the annuitants.

McAuliffe and others became owners of the investment instruments through Cranston estate planner Joseph Caramadre. Caramadre pleaded guilty to stealing the identities of terminally ill patients and using that information to falsely apply for annuities and bonds with death puts.

Prosecutors said Caramadre cost insurance companies between $37 million and $48 million from the scheme.

Caramadre, with the help of a partner, would use personal information from terminally ill patients on investment applications that contained death benefits. The actual owners of the annuity would be Caramadre or hundreds of investors. In exchange for the personal information, Caramadre often times would help the families of the terminally ill to pay for funeral expenses.

Besides McAuliffe, Robert Flanders, a former justice of the Rhode Island Supreme Court, is on the investment list. Gaythorne “Poochie” Angell, a long-time bookie and mob associate, was also an investor, along with Monsignor Raymond Bastia, who handles financial planning for the Roman Catholic Diocese of Providence.

There is no evidence that the investors knew that Caramadre was stealing the identities of the terminally ill patients.

For the entire story, click here.

See also:


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.